Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
Clinical trial NCT00600886 · COMPLETED
Trial details
- NCT number
- NCT00600886
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-11
- Primary completion
- 2016-03-11
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.